Zhang Wenzheng, Xia Xuefeng, Jalal Diana I, Kuncewicz Teresa, Xu William, Lesage Gene D, Kone Bruce C
Department of Internal Medicine, The University of Texas Medical School at Houston, 6431 Fannin, MSB 1.150, Houston, TX 77030, USA.
Am J Physiol Cell Physiol. 2006 Mar;290(3):C936-46. doi: 10.1152/ajpcell.00431.2005. Epub 2005 Oct 19.
Aldosterone is a major regulator of epithelial Na(+) absorption. One of its principal targets is the epithelial Na(+) channel alpha-subunit (ENaCalpha), principally expressed in the kidney collecting duct, lung, and colon. Models of aldosterone-mediated trans-activation of the ENaCalpha gene have focused primarily on interactions of liganded nuclear receptors with the ENaCalpha gene promoter. Herein, we demonstrate that the murine histone H3 lysine-79 methyltransferase, murine disruptor of telomeric silencing alternative splice variant "a" (mDot1a), is a novel component in the aldosterone signaling network controlling transcription of the ENaCalpha gene. Aldosterone downregulated mDot1a mRNA levels in murine inner medullary collecting ducts cells, which was associated with histone H3 K79 hypomethylation in bulk histones and at specific sites in the ENaCalpha 5'-flanking region, and trans-activation of ENaCalpha. Knockdown of mDot1a by RNA interference increased activity of a stably integrated ENaCalpha promoter-luciferase construct and expression of endogenous ENaCalpha mRNA. Conversely, overexpression of EGFP-tagged mDot1a resulted in hypermethylation of histone H3 K79 at the endogenous ENaCalpha promoter, repression of endogenous ENaCalpha mRNA expression, and decreased activity of the ENaCalpha promoter-luciferase construct. mDot1a-mediated histone H3 K79 hypermethylation and repression of ENaCalpha promoter activity was abolished by mDot1a mutations that eliminate its methyltransferase activity. Collectively, our data identify mDot1a as a novel aldosterone-regulated histone modification enzyme, and, through binding the ENaCalpha promoter and hypermethylating histone H3 K79 associated with the ENaCalpha promoter, a negative regulator of ENaCalpha transcription.
醛固酮是上皮细胞钠(Na⁺)重吸收的主要调节因子。其主要作用靶点之一是上皮钠通道α亚基(ENaCalpha),主要在肾集合管、肺和结肠中表达。醛固酮介导的ENaCalpha基因反式激活模型主要集中在配体结合核受体与ENaCalpha基因启动子的相互作用上。在此,我们证明小鼠组蛋白H3赖氨酸-79甲基转移酶,即端粒沉默破坏替代剪接变体“a”(mDot1a),是醛固酮信号网络中控制ENaCalpha基因转录的一个新成分。醛固酮下调小鼠髓质内集合管细胞中的mDot1a mRNA水平,这与整体组蛋白以及ENaCalpha 5'侧翼区域特定位点的组蛋白H3 K79低甲基化以及ENaCalpha的反式激活相关。通过RNA干扰敲低mDot1a可增加稳定整合的ENaCalpha启动子-荧光素酶构建体的活性以及内源性ENaCalpha mRNA的表达。相反,EGFP标记的mDot1a的过表达导致内源性ENaCalpha启动子处组蛋白H3 K79的高甲基化,抑制内源性ENaCalpha mRNA表达,并降低ENaCalpha启动子-荧光素酶构建体的活性。消除其甲基转移酶活性的mDot1a突变消除了mDot1a介导的组蛋白H3 K79高甲基化和ENaCalpha启动子活性的抑制。总体而言,我们的数据确定mDot1a是一种新型的醛固酮调节的组蛋白修饰酶,并且通过结合ENaCalpha启动子并使与ENaCalpha启动子相关的组蛋白H3 K79高甲基化,它是ENaCalpha转录的负调节因子。